Iris Behrmann

14.3k citations
92 papers · 11.6k indexed · 4 hit papers · h-index 46
  • Immunology top 0.2%
    • interferon and immune responses 15
    • Immune Cell Function and Interaction 8
  • Oncology top 0.2%
    • Cytokine Signaling Pathways and Interactions 56
    • MicroRNA in disease regulation 9
    • Melanoma and MAPK Pathways 9
    • Protein Tyrosine Phosphatases 9
  • Pharmacology top 0.5%
    • Pharmacological Effects of Natural Compounds 9
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 7

Iris Behrmann

90 papers receiving 11.3k citations

Hit Papers

Principles of interleukin (IL)-6-type cytokine signalling...2.6k199220262003201450010001.5k2.0k2.5k

Peers

Iris Behrmann
Comparison fields: 5 of 139
  • Immunology 4.4k
  • Oncology 5.0k
  • Cancer Research 1.9k
  • Molecular Biology 5.9k
  • Pharmacology 611
Replace Fred Schaper with:
Fred Schaper Germany
Koichi Nakajima Japan
Tracy A. Willson Australia
Jacqueline Bromberg United States
David A. Frank United States
Andrew C. Larner United States
Hideo Yasukawa Japan
Lawrence M. Pfeffer United States
Massimo Gadina United States
Chris Albanese United States
Iris Behrmann relative to Fred Schaper Germany Fred Schaper's profile →
Citations per field
00.5×1.5×1.8×
Fred Schaper · 1×
Citations per year

Countries citing papers authored by Iris Behrmann

Since Specialization
Citations

This map shows the geographic impact of Iris Behrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Behrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Behrmann more than expected).

Fields of papers citing papers by Iris Behrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Behrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Behrmann. The network helps show where Iris Behrmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Iris Behrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Behrmann Line = papers co-authored together Iris Behrmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2 201926
3 201617
4 201626
5 2013101
6 2010186
7 201012
8 200936
9 200750
10 200719
11 200550
12 200572
13 2003115
14 200266
15 200288
16 200163
17 200114
18 200139
19 200045
20 200019

About Iris Behrmann

Iris Behrmann is a scholar working on Oncology, Immunology and Pharmacology, having authored 92 papers that have together received 11.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (56 papers), interferon and immune responses (15 papers), MicroRNA in disease regulation (9 papers), Melanoma and MAPK Pathways (9 papers), Pharmacological Effects of Natural Compounds (9 papers), Protein Tyrosine Phosphatases (9 papers), Immune Cell Function and Interaction (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Immunology (4.4k citations), Oncology (5.0k citations) and Cancer Research (1.9k citations). Iris Behrmann has collaborated with scholars based in Germany, Luxembourg and Belgium. Frequent co-authors include Peter C. Heinrich, Fred Schaper, Gerhard Müller‐Newen, Serge Haan, Heike M. Hermanns, Lutz Graeve, Peter H. Krammer, Michael Pawlita, Claude Haan and Marcus E. Peter. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, The Journal of Immunology, FEBS Letters and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026